People: Novartis AG (NOVN.VX)

NOVN.VX on Virt-X Level 1

79.95CHF
25 Jul 2014
Price Change (% chg)

CHF-0.45 (-0.56%)
Prev Close
CHF80.40
Open
CHF80.15
Day's High
CHF80.45
Day's Low
CHF79.80
Volume
3,249,797
Avg. Vol
3,896,164
52-wk High
CHF81.70
52-wk Low
CHF65.70

Search Stocks

Brody, William 

Brief Biography

Dr. William R. Brody, M.D., Ph.D., serves as Member of the Board of Directors at Novartis AG since February 2009. He is also Member of the Compensation Committee of the Company. Dr. Brody was President of the Johns Hopkins University until the end of 2008 and is President of the United States-based Salk Institute for Biological Studies, La Jolla, California, United States. Previously he held various academic positions, including Professor for Radiology and Electrical Engineering at Stanford University and Professor and Director of the Department of Radiology at the Johns Hopkins University, both in the United States. Dr. Brody is President of the Salk Institute for Biological Studies. He is also Member of the Boards of Directors of the United States-based International Business Machines Corp. and Kool Smiles Inc., and the mutual funds boards of T. Rowe Price. He is Member of numerous professional associations, and also serves on the advisory boards of various government and nonprofit organizations. Dr. Brody earned his bachelors and masters degrees in electrical engineering from the Massachusetts Institute of Technology before completing his M.D. and Ph.D. at Stanford University, all in the United States.

Basic Compensation

Total Annual Compensation, CHF Long-Term Incentive Plans, CHF All Other, CHF Fiscal Year Total, CHF
262,500 -- 262,545 525,045

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Joerg Reinhardt

1,366,320

Joseph Jimenez

13,228,200

Ulrich Lehner

853,107

Harry Kirsch

--

Peter Kornicker

--

Felix Ehrat

3,584,790
As Of 30 Dec 2012
Search Stocks